Blocking PD-1/PD-L1 signaling has shown remarkable effectiveness in restoring T cells from an exhausted status, and normalizing the dysregulated TME, ultimately leading to cancer cell eradication (Cha et al., 2019). The gene discussed is PDCD1; the disease is cancer.